Retraction

miR-26a and its Target CKS2 Modulate Cell Growth and Tumorigenesis of Papillary Thyroid Carcinoma

Paper Information

Record ID:

27451

Author(s):

Mingli Lv
Xiaoping Zhang
Maoquan Li
Quanchi Chen
Meng Ye
Wenqing Liang
Lanbao Ding
Haidong Cai
Da Fu
Zhongwei Lv

Journal:

PLoS One ( PLoS )

Publication Date:

July 05, 2013

Retraction Date:

April 13, 2021 (4.6 years years ago)

Subjects:

Broad Categories:
Medicine Biology Genetics

Specific Fields:
Biology - Cancer Biology - Cellular Genetics Medicine - Endocrinology Medicine - Oncology

Institutions:

Country:

🇨🇳 China

Article Type:

Research Article

Publisher:

PLoS

Open Access:

Yes

DOI:

10.1371/journal.pone.0067591

PubMed ID:

23861775

Retraction PubMed ID:

33848306

Retraction Details

Retraction Reasons:

Nature of Retraction:

Retraction

Retraction Notice:

10.1371/journal.pone.0250313

Citations (40)

40

Total Citations

5

Post-Retraction
(12.5%)

34

Pre-Retraction

1

Same Day

Post-Retraction Citation Analysis

0 Within 30 days

1 Within 1 year

2 After 2+ years

868 Days since retraction (latest)

Aberrant expression of CKS2 induced by ELK1 contributes to malignant progression of pancreatic cancer

Qiuyang Chen, Yue Fu, Xinchun Liu et al. (9 authors)

Molecular Carcinogenesis

Published: Aug 2023
3 citations

868 days after retraction

Comprehensive analysis of the progression mechanisms of CRPC and its inhibitor discovery based on machine learning algorithms

Zhen Wang, Jing Zou, Le Zhang et al. (7 authors)

Frontiers in Genetics Open Access

Published: Jul 2023
3 citations

813 days after retraction

<i>In silico</i> analysis reveals hypoxia-induced miR-210-3p specifically targets SARS-CoV-2 RNA

Mirza Sarwar Baig, Deepanshu, Prem Prakash et al. (5 authors)

Journal of Biomolecular Structure and Dynamics

Published: Feb 2023
5 citations

666 days after retraction

High Expression of CKS2 Predicts Adverse Outcomes: A Potential Therapeutic Target for Glioma

Kai Yu, Yulong Ji, Min Liu et al. (10 authors)

Frontiers in Immunology Open Access

Published: May 2022
16 citations

401 days after retraction

MicroRNA and Alternative mRNA Splicing Events in Cancer Drug Response/Resistance: Potent Therapeutic Targets

Rahaba Marima, Flavia Zita Francies, Rodney Hull et al. (10 authors)

Biomedicines Open Access

Published: Dec 2021
27 citations

233 days after retraction

Retraction: miR-26a and its Target CKS2 Modulate Cell Growth and Tumorigenesis of Papillary Thyroid Carcinoma

Unknown Authors

PLoS ONE Open Access

Published: Apr 2021

Same day as retraction

CKS2 modulates cell‐cycle progression of tongue squamous cell carcinoma cells partly via modulating the cellular distribution of DUTPase

Fei Gao, Chong Li, Xiqun Zhao et al. (6 authors)

Journal of Oral Pathology and Medicine

Published: Oct 2020
13 citations

168 days before retraction

miR-26 family and its target genes in tumorigenesis and development

Chuangang Li, Yongyi Li, Yufeng Lu et al. (7 authors)

Critical Reviews in Oncology/Hematology

Published: Oct 2020
52 citations

175 days before retraction

Identification of hub genes associated with esophageal cancer progression using bioinformatics analysis

Jiangfen Li, Yufang Xie, Xueli Wang et al. (11 authors)

Oncology Letters Open Access

Published: Sep 2020
6 citations

216 days before retraction

LINC00657/miR-26a-5p/CKS2 ceRNA network promotes the growth of esophageal cancer cells via the MDM2/p53/Bcl2/Bax pathway

Xiaomei Zhang, Jian Wang, Zhulong Liu et al. (6 authors)

Bioscience Reports Open Access

Published: May 2020
27 citations

329 days before retraction

<p>MicroRNA-26a-5p inhibits proliferation, invasion and metastasis by repressing the expression of Wnt5a in papillary thyroid carcinoma</p>

Dongliang Shi, Haiyan Wang, Mingjian Ding et al. (7 authors)

OncoTargets and Therapy Open Access

Published: Aug 2019
39 citations

621 days before retraction

miR-26a promotes hepatocellular carcinoma invasion and metastasis by inhibiting PTEN and inhibits cell growth by repressing EZH2

Wentao Zhao, Xiaolin Lin, Yu Liu et al. (15 authors)

Laboratory Investigation Open Access

Published: Jun 2019
37 citations

669 days before retraction

Inhibitory effects of miR‑26b‑5p on thyroid cancer

Aiya Zhou, Gengyu Chen, Xiankui Cheng et al. (9 authors)

Molecular Medicine Reports Open Access

Published: May 2019
10 citations

683 days before retraction

Label-free Quantitative Analysis of Protein Expression Alterations in miR-26a-Knockout HeLa Cells using SWATH-MS Technology

Hexiao Shen, Li Li, Zhaowei Teng et al. (8 authors)

Scientific Reports Open Access

Published: Feb 2019
7 citations

799 days before retraction

EGFL7 promotes hepatocellular carcinoma cell proliferation and inhibits cell apoptosis through increasing CKS2 expression by activating Wnt/β‐catenin signaling

Zhi Li, Tongqing Xue, Chao Yang et al. (6 authors)

Journal of Cellular Biochemistry

Published: Aug 2018
24 citations

967 days before retraction

Identification of potential crucial genes and construction of microRNA-mRNA negative regulatory networks in osteosarcoma

Yue Pan, Lingyun Lu, Junquan Chen et al. (5 authors)

Hereditas Open Access

Published: May 2018
30 citations

1070 days before retraction

MicroRNA‑26a regulates ANXA1, rather than DAL‑1, in the development of lung cancer

Tonghui Cai, Xiaoyingï¿ ⁄ Guan, Hongyanï¿ ⁄ Wang et al. (7 authors)

Oncology Letters Open Access

Published: Feb 2018
5 citations

1154 days before retraction

MiR-26a inhibits thyroid cancer cell proliferation by targeting ARPP19.

Yanping Gong, Wenshuang Wu, Xiuhe Zou et al. (6 authors)

PubMed

Published: Jan 2018
26 citations

1198 days before retraction

[MicroRNA-26a and Tumor].

Qianqian Song, Ke Xu

DOAJ (DOAJ: Directory of Open Access Journals)

Published: Nov 2017
2 citations

1240 days before retraction

Micro<scp>RNA</scp>‐26a inhibits proliferation and tumorigenesis via targeting <scp>CKS</scp>2 in laryngeal squamous cell carcinoma

Zhiyan Wu, Baocai Lu, Xiao Li et al. (7 authors)

Clinical and Experimental Pharmacology and Physiology

Published: Nov 2017
16 citations

1244 days before retraction

The Cks1/Cks2 axis fine-tunes Mll1 expression and is crucial for MLL-rearranged leukaemia cell viability

William Grey, Adam Ivey, Thomas A. Milne et al. (8 authors)

Biochimica et Biophysica Acta (BBA) - Molecular Cell Research Open Access

Published: Sep 2017
16 citations

1301 days before retraction

Expression of MicroRNAs in Thyroid Carcinoma

Gaohong Zhu, Lijun Xie, Daniel Miller

Methods in molecular biology

Published: Jan 2017
18 citations

1563 days before retraction

Downregulation of serum miR-26a predicts poor clinical outcome of papillary thyroid carcinoma.

Guanghui Ren, Hongtao Li, Xiao-yan He et al. (4 authors)

PubMed

Published: Jan 2017
5 citations

1563 days before retraction

Different levels of serum microRNAs in prostate cancer and benign prostatic hyperplasia: evaluation of potential diagnostic and prognostic role

Giovanni Cochetti, Giulia Poli, Gabriella Guelfi et al. (6 authors)

OncoTargets and Therapy Open Access

Published: Dec 2016
100 citations

1594 days before retraction

MicroRNA-7 inhibits proliferation, migration and invasion of thyroid papillary cancer cells via targeting CKS2

Kaiyao Hua, Jiali Jin, Huiwen Zhang et al. (7 authors)

International Journal of Oncology Open Access

Published: Aug 2016
56 citations

1699 days before retraction

Cancer stem cells as a potential therapeutic target in thyroid carcinoma

Luisa Vicari, Cristina Colarossi, Dario Giuffrida et al. (5 authors)

Oncology Letters Open Access

Published: Aug 2016
26 citations

1715 days before retraction

microRNA-7 regulates cell growth, migration and invasion via direct targeting of PAK1 in thyroid cancer

Kai Yue, Xudong Wang, Yansheng Wu et al. (6 authors)

Molecular Medicine Reports Open Access

Published: Jul 2016
44 citations

1741 days before retraction

The role of microRNA-26a in human cancer progression and clinical application

Jing Chen, Kai Zhang, Yuejuan Xu et al. (7 authors)

Tumor Biology

Published: Apr 2016
51 citations

1837 days before retraction

MiR-26a and miR-144 inhibit proliferation and metastasis of esophageal squamous cell cancer by inhibiting cyclooxygenase-2

Ying Shao, Li Peng, Shengtao Zhu et al. (11 authors)

Oncotarget Open Access

Published: Mar 2016
51 citations

1866 days before retraction

MicroRNAs and Lymph Node Metastasis in Papillary Thyroid Cancers

Nurul‐Syakima Ab Mutalib, Azliana Mohamad Yusof, Norfilza Mohd Mokhtar et al. (6 authors)

Asian Pacific Journal of Cancer Prevention Open Access

Published: Feb 2016
26 citations

1894 days before retraction

MIRNAS in Astrocyte-Derived Exosomes as Possible Mediators of Neuronal Plasticity

Carlos Lafourcade, Juan Pablo Ramírez, Alejandro Luarte et al. (5 authors)

Journal of Experimental Neuroscience Open Access

Published: Jan 2016
93 citations

1929 days before retraction

Targeting c‐<scp>M</scp>et in Cancer by Micro<scp>RNA</scp>s: Potential Therapeutic Applications in Hepatocellular Carcinoma

Zeynep Fırtına Karagonlar, Peyda Korhan, Neşe Atabey

Drug Development Research

Published: Sep 2015
22 citations

2040 days before retraction

Enhanced phosphorylation of p53 by microRNA-26a leading to growth inhibition of pancreatic cancer

Ramesh B. Batchu, Oksana V. Gruzdyn, Aamer Qazi et al. (7 authors)

Surgery

Published: Jul 2015
23 citations

2098 days before retraction

The Role of MicroRNAs and Human Epidermal Growth Factor Receptor 2 in Proliferative Lupus Nephritis

Patrícia Costa‐Reis, Pierre A. Russo, Zhe Zhang et al. (10 authors)

Arthritis & Rheumatology Open Access

Published: May 2015
63 citations

2148 days before retraction

CKS2 in human cancers: Clinical roles and current perspectives (Review)

Hanyu You, Huayue Lin, Zhongying Zhang

Molecular and Clinical Oncology Open Access

Published: Feb 2015
41 citations

2260 days before retraction

MiR-146b-5p Promotes Metastasis and Induces Epithelial-Mesenchymal Transition in Thyroid Cancer by Targeting ZNRF3

Xianzhao Deng, Bo Wu, Xiao Ke et al. (7 authors)

Cellular Physiology and Biochemistry Open Access

Published: Jan 2015
141 citations

2294 days before retraction

Up-regulated CKS2 promotes tumor progression and predicts a poor prognosis in human colorectal cancer.

Minhao Yu, Yang Luo, Shao‐Lan Qin et al. (6 authors)

PubMed

Published: Jan 2015
42 citations

2294 days before retraction

miR-219–5p Modulates Cell Growth of Papillary Thyroid Carcinoma by Targeting Estrogen Receptor α

Chen Huang, Zhaogeng Cai, Mingzhu Huang et al. (14 authors)

The Journal of Clinical Endocrinology & Metabolism Open Access

Published: Nov 2014
52 citations

2331 days before retraction

MicroRNA-26a/b Regulate DNA Replication Licensing, Tumorigenesis, and Prognosis by Targeting CDC6 in Lung Cancer

Xin Zhang, Dakai Xiao, Ziyi Wang et al. (11 authors)

Molecular Cancer Research Open Access

Published: Aug 2014
60 citations

2441 days before retraction

Clinical and biological impact of cyclin-dependent kinase subunit 2 in esophageal squamous cell carcinoma

Yoshiaki Kita, Yuka Nishizono, Hiroshi Okumura et al. (17 authors)

Oncology Reports Open Access

Published: Mar 2014
28 citations

2596 days before retraction

Quick Stats

Total Citations: 40

Years Since Retraction: 4.6 years

Open Access: Yes

Last Checked: Jul 24, 2025

Actions

More from this journal Similar subjects View Original Paper View Retraction Notice

miR-26a and its Target CKS2 Modulate Cell Growth and Tumorigenesis of Papillary Thyroid Carcinoma

Paper Information

Institutions:

Country:

Retraction Details

Retraction Reasons:

Nature of Retraction:

Retraction Notice:

Citations (40)

40

5

34

1

Post-Retraction Citation Analysis

MiR-26a inhibits thyroid cancer cell proliferation by targeting ARPP19.

Downregulation of serum miR-26a predicts poor clinical outcome of papillary thyroid carcinoma.

Up-regulated CKS2 promotes tumor progression and predicts a poor prognosis in human colorectal cancer.

Quick Stats

Related Papers

Actions